Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 4
2011 4
2013 3
2014 1
2015 2
2016 4
2018 3
2019 4
2020 8
2021 9
2022 4
2023 10
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.
Ree IMC, de Haas M, van Geloven N, Juul SE, de Winter D, Verweij EJT, Oepkes D, van der Bom JG, Lopriore E. Ree IMC, et al. Among authors: de winter d. Lancet Haematol. 2023 Dec;10(12):e976-e984. doi: 10.1016/S2352-3026(23)00285-5. Lancet Haematol. 2023. PMID: 38030319 Clinical Trial.
Identification and management of fetal anemia due to hemolytic disease.
van 't Oever RM, Zwiers C, de Winter D, de Haas M, Oepkes D, Lopriore E, Verweij EJJ. van 't Oever RM, et al. Among authors: de winter d. Expert Rev Hematol. 2022 Nov;15(11):987-998. doi: 10.1080/17474086.2022.2138853. Epub 2022 Oct 31. Expert Rev Hematol. 2022. PMID: 36264850 Review.
Monoclonal RhD prophylaxis: high time to evaluate efficacy.
Verweij E, Tura AK, Gure T, Pyuza J, Mchome B, Kawaza K, Moons P, de Winter D, Van't Oever R, Spitalnik S, van der Schoot CE, van den Akker T; AFRICARhE consortium. Verweij E, et al. Among authors: de winter d. Lancet. 2024 Mar 2;403(10429):806-807. doi: 10.1016/S0140-6736(23)01888-3. Lancet. 2024. PMID: 38431342 No abstract available.
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus.
Mustafa HJ, Sambatur EV, Shamshirsaz AA, Johnson S, Moise KJ Jr, Baschat AA, Joanne Verweij EJT, Javinani A, Kilby MD, Lopriore E, Rose R, Devlieger R, Snowise S, Sachs UJ, Khalil A; HDFN Delphi Working Group. Mustafa HJ, et al. Am J Obstet Gynecol. 2024 Nov 14:S0002-9378(24)01130-X. doi: 10.1016/j.ajog.2024.11.003. Online ahead of print. Am J Obstet Gynecol. 2024. PMID: 39547350
58 results